Skip to main content

$0.130 0.025 (23.81%)

High

$0.13

Low

$0.11

Trades

273

Turnover

$1,647,025

Volume

13,196,801
30 June 2023 at 4:45pm
Register to track BOT and receive email alerts.
Subject
BOT Ann: Section 708A(5)(e) Notice

BOT Ann: Application for quotation of securities - BOT

BOT Ann: Section 708A(5)(e) Notice

BOT Ann: Application for quotation of securities - BOT

BOT Ann: Investor Webinar Presentation

BOT Ann: New Territory Licensed for Sofpironium Bromide with Kaken

BOT Ann: Pause in trading

BOT Ann: Botanix Investor Webinar

BOT Ann: Change of Director's Interest Notice x 3

BOT Ann: Notification of cessation of securities - BOT

BOT Ann: Appendix 2A and Section 708A(5)(e) Notice - amended

BOT Ann: Notice Under Section 708A(5)(e) of the Corporations Act

BOT Ann: Application for quotation of securities - BOT

BOT Ann: March 2023 Quarterly Activities Report and Appendix 4C

BOT Ann: Change in substantial holding from IFL

BOT Ann: Company Secretary Change

BOT Ann: Botanix successfully completes A$10m Placement Revised

BOT Ann: Botanix successfully completes A$10m Placement

BOT Ann: Notice under Section 708A(5)(e) of the Corporations Act

BOT Ann: Application for quotation of securities - BOT

BOT Ann: Application for quotation of securities - BOT

BOT Ann: Investor Update

BOT Ann: Proposed issue of securities - BOT

BOT Ann: Botanix Raises A$10 million via Institutional Placement

BOT Ann: Trading Halt

BOT Ann: FDA Mid-Cycle Review Meeting Successfully Completed

BOT Ann: Change of Director's Interest Notice * 5

BOT Ann: Notice under Section 708A(5)(e) of the Corporations Act

BOT Ann: Application for quotation of securities - BOT

BOT Ann: Application for quotation of securities - BOT

BOT Ann: Notification regarding unquoted securities - BOT

BOT Ann: Response to ASX Price and Volume Query

BOT Ann: Webinar Updated Commercial Research for Sofpironium Bromide

BOT Ann: Botanix To Host Investor Webinar

BOT Ann: Half Yearly Report and Accounts

BOT Ann: Press Article Correction

BOT Ann: Trading Halt

BOT Ann: Pause in Trading

BOT Ann: Investor Presentation and Video

BOT Ann: Appendix 4C - Quarterly

BOT Ann: Botanix attends JP Morgan Healthcare Conference

BOT Ann: Change of Director's Interest Notice * 5

BOT Ann: Notification regarding unquoted securities - BOT

BOT Ann: Change of Director's Interest Notice *5

BOT Ann: Notice under Section 708A(5)(e) of the Corporations Act

BOT Ann: Application for quotation of securities - BOT

BOT Ann: Notification regarding unquoted securities - BOT

BOT Ann: Confirmation Sofpironium Bromide NDA Formally Under Review

BOT Ann: Application for quotation of securities - BOT

BOT Ann: Notice Under Section 708A(5)(e) of the Corporations Act 2001

Register to track BOT and receive email alerts.

Similar Companies

CAN
CPH
EOF
IHL
MVP
MYX
NEU
PBP
RCE
SPL